PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.68%
Some net income increase while CRK is negative at -72.06%. John Neff would see a short-term edge over the struggling competitor.
-15.45%
Negative yoy D&A while CRK is 139.34%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
6.23%
Some yoy growth while CRK is negative at -75.32%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
366.67%
SBC growth well above CRK's 10.47%. Michael Burry would flag major dilution risk vs. competitor’s approach.
1933.33%
Slight usage while CRK is negative at -232.15%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1933.33%
Some yoy usage while CRK is negative at -799.39%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-38.95%
Both negative yoy, with CRK at -96.86%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-38.17%
Both yoy CFO lines are negative, with CRK at -160.17%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-0.95%
Negative yoy CapEx while CRK is 60.12%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-83.29%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-116.44%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
442.34%
Liquidation growth of 442.34% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
0.99%
Growth of 0.99% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-354.10%
We reduce yoy invests while CRK stands at 60.12%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-1508.54%
We cut debt repayment yoy while CRK is 98.73%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while CRK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.